109 related articles for article (PubMed ID: 8434804)
1. Combined effects of urokinase and heparin on PTT values during thrombolytic therapy.
Sheiman RG; Phillips DA
Angiology; 1993 Feb; 44(2):114-22. PubMed ID: 8434804
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of pro-urokinase in the treatment of deep vein thrombosis.
Moia M; Mannucci PM; Pini M; Prandoni P; Gurewich V
Thromb Haemost; 1994 Sep; 72(3):430-3. PubMed ID: 7531876
[TBL] [Abstract][Full Text] [Related]
3. [Fibrinogen-guided thrombolysis with urokinase of a portal and mesenterial venous thrombosis during an acute episode of ulcerative colitis].
Brueck M; Runde T; Rauber K; Kramer W
Dtsch Med Wochenschr; 2006 Jan; 131(3):84-8. PubMed ID: 16418946
[TBL] [Abstract][Full Text] [Related]
4. Recombinant pro-urokinase requires heparin for optimal clot lysis and restoration of blood flow in a canine femoral artery thrombosis model.
Burke SE; Lubbers NL; Nelson RA; Henkin J
Thromb Haemost; 1993 Apr; 69(4):375-80. PubMed ID: 8497850
[TBL] [Abstract][Full Text] [Related]
5. Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis.
Wasay M; Bakshi R; Kojan S; Bobustuc G; Dubey N; Unwin DH
Stroke; 2001 Oct; 32(10):2310-7. PubMed ID: 11588319
[TBL] [Abstract][Full Text] [Related]
6. Thrombolytic therapy for femoral artery thrombosis after left cardiac catheterization in children.
Liu Q; Yan CW; Zhao SH; Jiang SL; Xu ZY; Huang LJ; Ling J; Zheng H; Wang Y
Chin Med J (Engl); 2009 Apr; 122(8):931-4. PubMed ID: 19493417
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
Skeik N; Gits CC; Ehrenwald E; Cragg AH
Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
[TBL] [Abstract][Full Text] [Related]
8. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
9. High-dose urokinase therapy in newborn infants with major vessel thrombosis.
Giacoia GP
Clin Pediatr (Phila); 1993 Apr; 32(4):231-7. PubMed ID: 8462236
[TBL] [Abstract][Full Text] [Related]
10. Bleeding time and other laboratory tests to monitor the safety and efficacy of thrombolytic therapy.
Hirsch DR; Goldhaber SZ
Chest; 1990 Apr; 97(4 Suppl):124S-131S. PubMed ID: 2108850
[TBL] [Abstract][Full Text] [Related]
11. Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis.
Kase CS; O'Neal AM; Fisher M; Girgis GN; Ordia JI
Ann Intern Med; 1990 Jan; 112(1):17-21. PubMed ID: 2104561
[TBL] [Abstract][Full Text] [Related]
12. Bolus recombinant urokinase versus heparin in deep venous thrombosis: a randomized controlled trial.
Goldhaber SZ; Hirsch DR; MacDougall RC; Polak JF; Creager MA
Am Heart J; 1996 Aug; 132(2 Pt 1):314-8. PubMed ID: 8701892
[TBL] [Abstract][Full Text] [Related]
13. Studies on the medical treatment of deep vein thrombosis.
Schulman S
Acta Med Scand Suppl; 1985; 704():1-68. PubMed ID: 3913282
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator.
Lee K; Istl A; Dubois L; DeRose G; Forbes TL; Wiseman D; Mujoomdar A; Kribs S; Power AH
Vasc Endovascular Surg; 2015 Oct; 49(7):175-9. PubMed ID: 26462979
[TBL] [Abstract][Full Text] [Related]
15. Major Bleeding During Thrombolytic Therapy for Acute Lower Limb Ischaemia: Value of Laboratory Tests for Clinical Decision Making, 17 Years of Experience.
Doelare SAN; Oukrich S; Ergin K; Jongkind V; Wiersema AM; Lely RJ; Ebben HP; Yeung KK; Hoksbergen AWJ;
Eur J Vasc Endovasc Surg; 2023 Mar; 65(3):398-404. PubMed ID: 36343749
[TBL] [Abstract][Full Text] [Related]
16. Combined thrombolytic therapy for atrial thrombus in a preterm infant.
Mondì V; Di Paolo A; Fabiano A; Cicchese M; De Merulis G; Giannini C; Del Principe D
Minerva Pediatr; 2011 Apr; 63(2):115-8. PubMed ID: 21487375
[TBL] [Abstract][Full Text] [Related]
17. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions.
Sugimoto K; Hofmann LV; Razavi MK; Kee ST; Sze DY; Dake MD; Semba CP
J Vasc Surg; 2003 Mar; 37(3):512-7. PubMed ID: 12618684
[TBL] [Abstract][Full Text] [Related]
18. Thrombolytic therapy for acute arterial occlusion.
Sicard GA; Schier JJ; Totty WG; Gilula LA; Walker WB; Etheredge EE; Anderson CB
J Vasc Surg; 1985 Jan; 2(1):65-78. PubMed ID: 3965760
[TBL] [Abstract][Full Text] [Related]
19. Deep vein thrombosis: a mininvasive locoregional thrombolytic treatment.
Ippolito E; Molinari A; Romagnoli S; Belcaro G; Cesarone MR; Urgnani F; Bonadeo P
Minerva Cardioangiol; 2008 Oct; 56(5 Suppl):63-70. PubMed ID: 19597411
[TBL] [Abstract][Full Text] [Related]
20. Bleeding and thrombosis in high-risk renal transplantation candidates using heparin.
Mathis AS; Davé N; Shah NK; Friedman GS
Ann Pharmacother; 2004 Apr; 38(4):537-43. PubMed ID: 14766999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
